Details for New Drug Application (NDA): 060575
NDA 060575 describes MYCOSTATIN, which is a drug marketed by Delcor Asset Corp and is included in seven NDAs. Additional details are available on the MYCOSTATIN profile page.
The generic ingredient in MYCOSTATIN is nystatin. There is one drug master file entry for this compound. Forty suppliers are listed for this compound. Additional details are available on the nystatin profile page.
The generic ingredient in MYCOSTATIN is nystatin. There is one drug master file entry for this compound. Forty suppliers are listed for this compound. Additional details are available on the nystatin profile page.
Summary for 060575
| Tradename: | MYCOSTATIN |
| Applicant: | Delcor Asset Corp |
| Ingredient: | nystatin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 060575
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 100,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
